Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 30 January 1998:
Vol. 279. no. 5351, p. 648
DOI: 10.1126/science.279.5351.648
Prev | Table of Contents | Next

News

XENOTRANSPLANTS:
No Moratorium on Clinical Trials

Gretchen Vogel

U.S. health officials last week said they will allow limited clinical trials of animal-to-human transplantation to proceed, even though some researchers argue that such work poses a risk to public health and should not be permitted without further study. At a meeting on 21 and 22 January, officials from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the National Institutes of Health outlined plans to allow this research to go forward under stringent safeguards that are now being finalized. They intend to impose rigorous standards to maintain disease-free donor animals, create a national registry of organ recipients, and establish both a tissue bank of samples from donor animals and recipients and a national policy advisory committee.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Reliable Method for Isolation of Viable Porcine Islet Cells.
C. D. Ching, R. C. Harland, B. H. Collins, W. Kendall, H. Hobbs, and E. C. Opara (2001)
Arch Surg 136, 276-279
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)